Personal Genome Diagnostics And Cleveland Diagnostics Will Use New Funding To Expand Cancer Portfolios
Personal Genome Diagnostics will use its funding to expand its liquid biopsy portfolio. Cleveland Diagnostics plans to develop early detection tests for lung and breast cancer.
You may also be interested in...
Minute Insight: Quidel And Labcorp Finish Big Year For IVD Deals With Major Acquisitions
Quidel will pay $6bn for Ortho Clinical Diagnostics. Labcorp will acquire Personal Genome Diagnostics for $575m.
Wi-Fi Failures, Custom Tech And Other Challenges Of Bringing Specialty Care Into Patients’ Homes
The CEOs Reimagine Care, Cortica and Inbound Health, part of the rising trend to bring specialty and acute care programs into the home, joined a panel at the DHIS West conference to discuss their views on the future of virtual and at-home delivery of complex care and shared some of their own challenges they encountered.
Minute Insight: Thermo Fisher Scientific Wins FDA Clearance For Preeclampsia Blood Test
The FDA cleared Thermo Fisher’s in vitro diagnostic for preeclampsia, the leading cause of pregnancy morbidity and mortality, based on results from the PRAECIS study.